Diabetologia

, Volume 45, Issue 3, pp 420–426

Coenzyme Q10 improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus

  • G. F. Watts
  • D. A. Playford
  • K. D. Croft
  • N. C. Ward
  • T. A. Mori
  • V. Burke
Article

DOI: 10.1007/s00125-001-0760-y

Cite this article as:
Watts, G., Playford, D., Croft, K. et al. Diabetologia (2002) 45: 420. doi:10.1007/s00125-001-0760-y

Abstract.

Aim/hypothesis:

We assessed whether dietary supplementation with coenzyme Q10 improves endothelial function of the brachial artery in patients with Type II (non-insulin-dependent) diabetes mellitus and dyslipidaemia.

Methods:

A total of 40 patients with Type II diabetes and dyslipidaemia were randomized to receive 200 mg of coenzyme Q10 or placebo orally for 12 weeks. Endothelium-dependent and independent function of the brachial artery was measured as flow-mediated dilatation and glyceryl-trinitrate-mediated dilatation, respectively. A computerized system was used to quantitate vessel diameter changes before and after intervention. Arterial function was compared with 18 non-diabetic subjects. Oxidative stress was assessed by measuring plasma F2-isoprostane concentrations, and plasma antioxidant status by oxygen radical absorbance capacity.

Results:

The diabetic patients had impaired flow-mediated dilation [3.8 % (SEM 0.5) vs 6.4 % (SEM 1.0), p = 0.016], but preserved glyceryl-trinitrate-mediated dilation, of the brachial artery compared with non-diabetic subjects. Flow-mediated dilation of the brachial artery increased by 1.6 % (SEM 0.3) with coenzyme Q10 and decreased by –0.4 % (SEM 0.5) with placebo (p = 0.005); there were no group differences in the changes in pre-stimulatory arterial diameter, post-ischaemic hyperaemia or glyceryl-trinitrate-mediated dilation response. Coenzyme Q10 treatment resulted in a threefold increase in plasma coenzyme Q10 (p < 0.001) but did not alter plasma F2-isoprostanes, oxygen radical absorbance capacity, lipid concentrations, glycaemic control or blood pressure.

Conclusion/interpretation:

Coenzyme Q10 supplementation improves endothelial function of conduit arteries of the peripheral circulation in dyslipidaemic patients with Type II diabetes. The mechanism could involve increased endothelial release and/or activity of nitric oxide due to improvement in vascular oxidative stress, an effect that might not be reflected by changes in plasma F2-isoprostane concentrations. [Diabetologia (2002) 45: 420–426]

Keywords Coenzyme Q10endothelial functionnitric oxidediabetes.
Download to read the full article text

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • G. F. Watts
    • 1
  • D. A. Playford
    • 1
  • K. D. Croft
    • 1
  • N. C. Ward
    • 1
  • T. A. Mori
    • 1
  • V. Burke
    • 1
  1. 1.Department of Medicine, University of Western Australia, Royal Perth Hospital, Perth, AustraliaAU